This website is intended for healthcare professionals only
Specialities

Specialities

Alzheimer's Disease and Dementia
Brain Trauma
COVID-19
Epilepsy
Headache Disorders
Neurodegenerative Diseases
Movement Disorders
Multiple Sclerosis
Neuroimmunology
Neurological Oncology
Neurometabolic Disease
Neuromuscular Diseases
Neuropathic Pain
Stroke
Neurosurgery
Pediatric Neurology
Parkinson's Disease
Psychiatric Disorders
Rare Diseases
Sleep Disorders
Central Nervous Disorders
Neuroradiology
Search

Trending Topic

Conceptual design with brain and red abstract background. Horizontal banner.
15 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Mechanical thrombectomy: Evidence basis and future directions

Abdelmageet Hassan, Sumanjit Gill

Both intracerebral hemorrhage and ischemic stroke continue to be the leading causes of disability and the second leading causes of death worldwide.1,2 The burden is largest in low- and middle-income countries, which have seen rapid recent population growth. Large vessel occlusion (LVO – internal carotids, vertebrals and the proximal branches of the circle of Willis) accounts for 20% of all acute ischemic strokes (AISs) […]

touchREVIEWS in Neurology. 2026;22(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Search Results

2 Results Found for “senolytics”

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

From Ageing Biology to Alzheimer’s Therapy: Integrating Geroscience, Lifestyle and Pharmacological Strategies

Khaled Abdel-sater

Between 60% and 80% of cases with dementia worldwide are caused by Alzheimer’s disease (AD), making it the most prevalent type of dementia.1 As of 2025, approximately 60 million people worldwide are affected by dementia, and by 2050, projections suggest a rise to nearly 210 ...

touchREVIEWS in Neurology. 2025;21(1):5-13
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

Could senolytics change the treatment landscape of age-related diseases?

In this episode, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential to advance the treatment of age-related diseases. From understanding the science behind cellular senescence to how senolytic drugs work and what early clinical trials reveal, this episode explores an exciting frontier in longevity medicine.

Latest articles videos and clinical updates - straight to your inbox

Close Popup